:
Chronic inflammation mediated by microglia is a cause of some neuroinflammatory diseases.
TLR4, a natural immune receptor on microglia, plays an important role in the occurrence of
inflammation and the process of diseases. TLR4 can be activated by a variety of ligands to trigger
inflammatory responses, including endogenous ligands HMGB1, S100A8/9, Heme, and Fetuin-A.
As ligands derived from the body itself, they have the ability to bind directly to TLR4 and can be
used as inducers of aseptic inflammation. In the past 20 years, targeting ligands rather than receptors
has become an emerging therapeutic strategy for the treatment of diseases, so understanding
the relationship between microglia, TLR4, TLR4 ligands, and corresponding diseases may have
new implications for the treatment of diseases. In the article, we will discuss the TLR4 and the endogenous
substances that can activate the TLR4 signaling pathway and present literature support
for their role in neuroinflammatory diseases.